Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Legend Biotech (NASDAQ: LEGN), a global cell therapy leader, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. CEO Ying Huang, Ph.D., will deliver company updates at the event in San Francisco on January 14, 2025, at 3:45 p.m. PT. The presentation will be accessible via live audio webcast through Legend's Investor Relations website section, with a replay available approximately 48 hours after the event.
Legend Biotech (NASDAQ: LEGN), un leader globale nella terapia cellulare, ha annunciato la sua partecipazione al 43° Convegno Annuale della J.P. Morgan Healthcare. Il CEO Ying Huang, Ph.D., presenterà gli aggiornamenti aziendali durante l'evento a San Francisco il 14 gennaio 2025, alle 15:45 PT. La presentazione sarà accessibile tramite webcast audio in diretta nella sezione dedicata delle Relazioni con gli Investitori di Legend, con una registrazione disponibile circa 48 ore dopo l'evento.
Legend Biotech (NASDAQ: LEGN), un líder global en terapia celular, ha anunciado su participación en la 43ª Conferencia Anual de Salud de J.P. Morgan. El CEO Ying Huang, Ph.D., ofrecerá actualizaciones de la empresa en el evento en San Francisco el 14 de enero de 2025, a las 15:45 PT. La presentación estará disponible a través de una transmisión de audio en vivo en la sección de Relación con Inversores del sitio web de Legend, con una repetición disponible aproximadamente 48 horas después del evento.
Legend Biotech (NASDAQ: LEGN), 글로벌 세포 치료의 선두주자인 Legend Biotech가 제43회 JP모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. CEO Ying Huang 박사가 2025년 1월 14일 오후 3시 45분 PT에 샌프란시스코에서 회사 업데이트를 발표할 예정입니다. 발표 내용은 Legend의 투자자 관계 웹사이트 섹션을 통해 실시간 오디오 웹캐스트로 제공되며, 이벤트 후 약 48시간 후에 재생 가능합니다.
Legend Biotech (NASDAQ: LEGN), un leader mondial en thérapie cellulaire, a annoncé sa participation à la 43e Conférence Annuelle de J.P. Morgan Healthcare. Le PDG Ying Huang, Ph.D., présentera des mises à jour de l'entreprise lors de l'événement à San Francisco le 14 janvier 2025 à 15h45 PT. La présentation sera accessible via un webinaire audio en direct sur la section des Relations Investisseurs du site de Legend, avec un replay disponible environ 48 heures après l'événement.
Legend Biotech (NASDAQ: LEGN), ein globaler Marktführer in der Zelltherapie, hat seine Teilnahme an der 43. J.P. Morgan Healthcare-Konferenz bekannt gegeben. CEO Ying Huang, Ph.D., wird am 14. Januar 2025 um 15:45 Uhr PT Neuigkeiten über das Unternehmen auf der Veranstaltung in San Francisco präsentieren. Die Präsentation wird über einen Live-Audio-Webcast auf der Investor Relations-Website von Legend zugänglich sein, mit einer Wiederholung, die ungefähr 48 Stunden nach der Veranstaltung verfügbar ist.
- None.
- None.
SOMERSET, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will present the latest company updates at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Tuesday, January 14, 2025, at 3:45 p.m. PT.
Investors and other interested parties can access the live audio webcast through the Investor Relations section of Legend’s website. The webcast replay will be available approximately 48 hours after the webcast.
About Legend Biotech
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.
Learn more at https://legendbiotech.com and follow us on X (formerly Twitter) and LinkedIn.
INVESTOR CONTACT:
Jessie Yeung
Tel: (732) 956-8271
jessie.yeung@legendbiotech.com
PRESS CONTACT:
Mary Ann Ondish
Tel: (914) 552-4625
media@legendbiotech.com
FAQ
When is Legend Biotech (LEGN) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors access Legend Biotech's (LEGN) J.P. Morgan Healthcare Conference presentation?
When will the replay of Legend Biotech's (LEGN) J.P. Morgan presentation be available?
Who is presenting for Legend Biotech (LEGN) at the 2025 J.P. Morgan Healthcare Conference?
Which annual J.P. Morgan Healthcare Conference is Legend Biotech (LEGN) presenting at?
